Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>CEBP</i> and <i>ZEB2</i> alterations define three distinct subtypes of B-cell acute lymphoblastic leukemia.

HemaSphere·2026
Same author

Persistent <i>BCR::ABL1</i>-positive preleukemic stem cells drive late clonal evolution in Philadelphia chromosome-positive ALL.

HemaSphere·2026
Same author

Predisposition to ALL and Solid Tumors Rather Than Bone Marrow Failure in <i>FANCM</i>-Associated Fanconi Anemia.

JCO precision oncology·2026
Same author

Metabolite-induced DNA damage drives stochastic stem cell loss and clonal hematopoiesis.

Cell stem cell·2026
Same author

MDM4 haploinsufficiency leads to p53-mediated bone marrow failure.

Blood·2026
Same author

MMS22L is a novel key actor of normal and pathological erythropoiesis.

HemaSphere·2025

Related Experiment Video

Updated: May 26, 2026

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

Fanconi anemia.

Jean Soulier1

  • 1Hôpital Saint-Louis, Paris, France. jean.soulier@sls.aphp.fr

Hematology. American Society of Hematology. Education Program
|December 14, 2011
PubMed
Summary
This summary is machine-generated.

Fanconi anemia (FA), a rare inherited bone marrow failure disorder, involves genetic defects leading to progressive bone marrow failure and increased leukemia risk. Understanding FA

More Related Videos

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

In Ovo Xenografting of Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells (PDX-ALL)
06:48

In Ovo Xenografting of Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells (PDX-ALL)

Published on: August 1, 2025

Related Experiment Videos

Last Updated: May 26, 2026

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

In Ovo Xenografting of Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells (PDX-ALL)
06:48

In Ovo Xenografting of Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells (PDX-ALL)

Published on: August 1, 2025

Area of Science:

  • Hematology
  • Genetics
  • Oncology

Background:

  • Fanconi anemia (FA) is the most common inherited bone marrow failure (BMF) disorder.
  • Fifteen FANC genes are known, with FANCA, FANCC, FANCG, and FANCD2 being most prevalent.
  • Diagnosis can be challenging, requiring tools like skin fibroblast analysis for atypical cases.

Purpose of the Study:

  • To investigate the underlying cellular mechanisms of hematopoietic defects in FA.
  • To understand the molecular basis of clonal evolution and cancer development in FA patients.
  • To improve diagnostic strategies and therapeutic approaches for FA.

Main Methods:

  • Analysis of skin fibroblasts for diagnostic confirmation.
  • Study of cellular mechanisms in hematopoietic failure.
  • Investigation of somatic chromosomal lesions in myelodysplasia syndrome (MDS) and acute myeloid leukemia (AML) in FA patients.

Main Results:

  • FA patients face selective pressure in bone marrow, promoting clonal evolution.
  • MDS and AML emerge in FA patients with characteristic chromosomal abnormalities.
  • Cellular mechanisms for BMF and clonal evolution in FA remain largely unknown.

Conclusions:

  • Elucidating FA mechanisms is crucial for understanding disease pathophysiology.
  • Improved understanding will aid in adapting patient follow-up and treatment.
  • FA serves as a model genetic condition for aplastic anemia, MDS/AML research.